{"product_id":"global-human-gene-therapy-market-growth-2023-2029","title":"Global Human Gene Therapy Market Growth 2023-2029","description":"\u003cp\u003eGlobal Human Gene Therapy Market Growth 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eGene therapy is a medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person's genetic makeup instead of using drugs or surgery.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Human Gene Therapy Industry Forecast” looks at past sales and reviews total world Human Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Gene Therapy sales for 2023 through 2029. With Human Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Gene Therapy industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Human Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Human Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Gene Therapy market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Gene Therapy.\u003c\/p\u003e\n\n\u003cp\u003eThe global Human Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eUnited States market for Human Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eChina market for Human Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eEurope market for Human Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eGlobal key Human Gene Therapy players cover Biogen, Sarepta Therapeutics, Gilead Sciences, Amgen, Novartis, Orchard Therapeutics, Spark Therapeutics, Agc Biologics and Anges, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Human Gene Therapy market by product type, application, key manufacturers and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nNon-viral Vectors\u003cbr\u003e\nViral Vectors\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nNeurological Diseases\u003cbr\u003e\nCancer\u003cbr\u003e\nDMD (Duchenne Muscular Dystrophy)\u003cbr\u003e\nHepatological Diseases\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\n    United States\u003cbr\u003e\n    Canada\u003cbr\u003e\n    Mexico\u003cbr\u003e\n    Brazil\u003cbr\u003e\nAPAC\u003cbr\u003e\n    China\u003cbr\u003e\n    Japan\u003cbr\u003e\n    Korea\u003cbr\u003e\n    Southeast Asia\u003cbr\u003e\n    India\u003cbr\u003e\n    Australia\u003cbr\u003e\nEurope\u003cbr\u003e\n    Germany\u003cbr\u003e\n    France\u003cbr\u003e\n    UK\u003cbr\u003e\n    Italy\u003cbr\u003e\n    Russia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\n    Egypt\u003cbr\u003e\n    South Africa\u003cbr\u003e\n    Israel\u003cbr\u003e\n    Turkey\u003cbr\u003e\n    GCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nBiogen\u003cbr\u003e\nSarepta Therapeutics\u003cbr\u003e\nGilead Sciences\u003cbr\u003e\nAmgen\u003cbr\u003e\nNovartis\u003cbr\u003e\nOrchard Therapeutics\u003cbr\u003e\nSpark Therapeutics\u003cbr\u003e\nAgc Biologics\u003cbr\u003e\nAnges\u003cbr\u003e\nBluebird Bio\u003cbr\u003e\nJazz Pharmaceuticals\u003cbr\u003e\nDynavax Technologies\u003cbr\u003e\nHuman Stem Cells Institute\u003cbr\u003e\nSibiono Genetech\u003cbr\u003e\nShanghai Sunway Biotech\u003cbr\u003e\nUniqure N.V.\u003cbr\u003e\nGensight Biologics S.A.\u003cbr\u003e\nCelgene Corporation\u003cbr\u003e\nCellectis\u003cbr\u003e\nSangamo Therapeutics\u003cbr\u003e\nMustang Bio\u003cbr\u003e\nAGTC\u003cbr\u003e\nPoseida Therapeutics\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Addressed in this Report\u003c\/p\u003e\n\n\u003cp\u003eWhat is the 10-year outlook for the global Human Gene Therapy market?\u003c\/p\u003e\n\n\u003cp\u003eWhat factors are driving Human Gene Therapy market growth, globally and by region?\u003c\/p\u003e\n\n\u003cp\u003eWhich technologies are poised for the fastest growth by market and region?\u003c\/p\u003e\n\n\u003cp\u003eHow do Human Gene Therapy market opportunities vary by end market size?\u003c\/p\u003e\n\n\u003cp\u003eHow does Human Gene Therapy break out type, application?\u003c\/p\u003e\n\n\u003cp\u003eWhat are the influences of COVID-19 and Russia-Ukraine war?\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 121 Pages \/ MCW16227416","offer_id":47645956505906,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-human-gene-therapy-market-growth-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}